Hisashi Kai

10.8k total citations · 2 hit papers
129 papers, 6.0k citations indexed

About

Hisashi Kai is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hisashi Kai has authored 129 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Cardiology and Cardiovascular Medicine, 28 papers in Physiology and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hisashi Kai's work include Blood Pressure and Hypertension Studies (28 papers), Nitric Oxide and Endothelin Effects (21 papers) and Hormonal Regulation and Hypertension (19 papers). Hisashi Kai is often cited by papers focused on Blood Pressure and Hypertension Studies (28 papers), Nitric Oxide and Endothelin Effects (21 papers) and Hormonal Regulation and Hypertension (19 papers). Hisashi Kai collaborates with scholars based in Japan, United States and Switzerland. Hisashi Kai's co-authors include Tsutomu Imaizumi, Mamiko Kai, Fumitaka Kuwahara, Keisuke Tokuda, Kensuke Egashira, Akira Takeshita, Nobuhiro Tahara, Hideo Yasukawa, Masaru Sugimachi and Hiroyuki Nakaura and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Hisashi Kai

125 papers receiving 5.9k citations

Hit Papers

Transforming Growth Factor-β Function Blocking Prevents M... 1998 2026 2007 2016 2002 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisashi Kai Japan 39 2.9k 1.4k 1.1k 1.0k 991 129 6.0k
William H. Schenke United States 33 3.5k 1.2× 2.2k 1.6× 935 0.8× 951 0.9× 1.4k 1.4× 71 7.4k
Gilles W. De Keulenaer Belgium 39 4.8k 1.6× 1.9k 1.4× 827 0.7× 672 0.7× 995 1.0× 100 7.5k
Ken Okumura Japan 45 4.5k 1.6× 1.2k 0.8× 952 0.9× 711 0.7× 1.2k 1.2× 268 7.4k
Yoshihiro Fukumoto Japan 49 3.6k 1.2× 2.1k 1.5× 1.5k 1.3× 2.4k 2.4× 1.7k 1.7× 309 8.6k
Masatsugu Hori Japan 53 3.6k 1.3× 2.0k 1.5× 678 0.6× 1.0k 1.0× 1.7k 1.7× 197 8.2k
Koichi Kaikita Japan 41 3.8k 1.3× 1.0k 0.7× 559 0.5× 662 0.7× 1.4k 1.4× 308 6.9k
Tohru Izumi Japan 39 3.7k 1.3× 1.3k 0.9× 865 0.8× 1.1k 1.1× 869 0.9× 294 6.5k
Fumitaka Ohsuzu Japan 42 1.6k 0.5× 975 0.7× 464 0.4× 780 0.8× 1.0k 1.0× 204 5.0k
Michael Buerke Germany 44 2.5k 0.9× 1.4k 1.1× 694 0.6× 661 0.7× 1.8k 1.8× 193 6.6k
Tomohiro Sakamoto Japan 44 3.4k 1.2× 1.1k 0.8× 621 0.6× 790 0.8× 1.7k 1.7× 213 6.6k

Countries citing papers authored by Hisashi Kai

Since Specialization
Citations

This map shows the geographic impact of Hisashi Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisashi Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisashi Kai more than expected).

Fields of papers citing papers by Hisashi Kai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisashi Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisashi Kai. The network helps show where Hisashi Kai may publish in the future.

Co-authorship network of co-authors of Hisashi Kai

This figure shows the co-authorship network connecting the top 25 collaborators of Hisashi Kai. A scholar is included among the top collaborators of Hisashi Kai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisashi Kai. Hisashi Kai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ogoyama, Yukako, Makiko Abe, Keisuke Okamura, et al.. (2024). Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials. Hypertension Research. 47(10). 2745–2759. 9 indexed citations
4.
Kario, Kazuomi, Hisashi Kai, Shinsuke Nanto, & Hiroyoshi Yokoi. (2023). Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation. Hypertension Research. 46(8). 2044–2047. 20 indexed citations
5.
Katoh, Atsushi, Hisao Ikeda, Motoki Sasaki, et al.. (2020). Long‐chain fatty acids in sarcopenia patients with cardiovascular diseases: importance of n‐9 monounsaturated fatty acids. SHILAP Revista de lepidopterología. 5(4). 121–128. 4 indexed citations
6.
Kai, Hisashi, Atsushi Katoh, Haruhito Harada, et al.. (2020). Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1. Hypertension Research. 43(7). 715–723. 3 indexed citations
7.
8.
Harada, Haruhito, Hisashi Kai, Hiroshi Niiyama, et al.. (2016). Effectiveness of cardiac rehabilitation for prevention and treatment of sarcopenia in patients with cardiovascular disease - a retrospective cross-sectional analysis. The journal of nutrition health & aging. 21(4). 449–456. 44 indexed citations
11.
Yasukawa, Hideo, Hisashi Kai, Daisuke Fukui, et al.. (2009). Reduction and activation of circulating dendritic cells in patients with decompensated heart failure. International Journal of Cardiology. 147(2). 258–264. 23 indexed citations
12.
Koga, Mitsuhisa, Hisashi Kai, Hideo Yasukawa, et al.. (2007). Inhibition of Progression and Stabilization of Plaques by Postnatal Interferon-γ Function Blocking in ApoE-Knockout Mice. Circulation Research. 101(4). 348–356. 77 indexed citations
13.
Koga, Mitsuhisa, Hisashi Kai, Hideo Yasukawa, et al.. (2007). Postnatal Blocking of Interferon-.GAMMA. Function Prevented Atherosclerotic Plaque Formation in Apolipoprotein E-Knockout Mice. Hypertension Research. 30(3). 259–267. 20 indexed citations
14.
Tahara, Nobuhiro, Hisashi Kai, Masatoshi Ishibashi, et al.. (2006). Simvastatin Attenuates Plaque Inflammation. Journal of the American College of Cardiology. 48(9). 1825–1831. 478 indexed citations
15.
Niiyama, Hiroshi, Hisashi Kai, Toshifumi Shimada, et al.. (2003). An Important Role of MCP-1 in Ischemia-Induced Angiogensis. Japanese Circulation Journal-english Edition. 67. 411–412. 1 indexed citations
16.
Shibata, Rei, Hisashi Kai, Yukihiko Seki, et al.. (2003). Rho-Kinase Inhibition Reduces Neointima Formation after Vascular Injury by Enhancing Bax Expression and Apoptosis. Journal of Cardiovascular Pharmacology. 42. S43–S47. 36 indexed citations
17.
Suzuki, Kazuo, et al.. (2002). Free Surface Potential Flow around Multi-Hulls in Shallow Water Using a Potential Based Panel Method. 2002(238). 29–38. 3 indexed citations
19.
Ikeda, Hisao, Takafumi Ueno, Hisashi Kai, et al.. (1997). Vasospastic angina induced by nonsteroidal anti‐inflammatory drugs. Clinical Cardiology. 20(7). 656–658. 25 indexed citations
20.
Yamamoto, Hideo, et al.. (1990). -0916-EVALUATION OF ENDOTHELIAL FUNCTION OF SPASTIC SEGMENT IN THE PATIENTS OF VARIANT ANGINA : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY. Japanese Circulation Journal-english Edition. 54(8). 975. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026